NASDAQ (USD): Cullinan Oncology, Inc. (CGEM)
Last Price
10.71
Today's Change
-0.33 (2.98%)
Day's Change
10.68 - 11.31
Trading Volume
95,509
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Fed’s Waller Supports Further Cuts, Says Inflation Moving Lower
2
Extreme Weather Drives Insured Losses to Highest Since 2017
3
Los Angeles Struggles to Battle Fires as Pentagon Offers Aid
4
Biden to Further Limit Nvidia AI Chip Exports in Final Push
5
Wall Street May Lose Up to 200,000 Jobs as AI Takes Over Their Roles
#
Stock
Score
BABA
Alibaba Group Holding Limited
META
Meta Platforms, Inc.
842
DDD
3D Systems Corporation
789
CNX
CNX Resources Corporation
526
BOH
Bank of Hawaii Corporation
6
AGN
7
E
Eni S.p.A.
8
BX
Blackstone Inc.
9
TSLA
Tesla, Inc.
10
CRM
Salesforce, Inc.
Last
Change
Volume
ERNA
0.794
+0.485
439,907,693
LICN
0.489
-1.631
183,350,854
RGTI
6.89
+0.84
152,683,842
NMHI
2.46
+1.33
140,469,390
QUBT
15.14
-10.54
120,604,778
LMDX
0.016
-0.018
120,553,903
LILM
0.209
-0.334
112,784,715
AIFF
3.60
+1.70
106,359,261
NVDA
131.41
-1.815
90,730,395
MU
87.09
-16.81
87,924,604
BRK-A
667,693.52
+1,413.50
594
NVR
8,132.00
+170.00
8,771
HEES
90.24
+46.30
7,867,652
MKL
1,711.74
+41.77
21,739
FCNCA
2,119.90
+34.29
10,778
FICO
1,938.67
+26.69
30,503
URI
715.70
+26.55
351,158
MELI
1,765.79
+25.79
63,837
BKNG
4,788.34
+24.44
34,561
UI
384.70
+22.27
64,236
1,774.05
-343.25
2,940,447
MSTR
1,309.00
-138.99
2,237,917
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
LLY
742.77
-54.71
5,359,982
RYVLX
562.73
-43.79
0
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....